Wexford Capital LP Fusion Pharmaceuticals Inc. Transaction History

Wexford Capital LP

  • $382 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$7.9 - $21.32 $395,000 - $1.07 Million
50,000 New
50,000 $1.07 Million

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Wexford Capital LP Portfolio

Follow Wexford Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Wexford Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email